Research for the development of a new fuel with low enrichment: Teresa Kiechle and Julian Becker  in the uranium laboratory of the FRM II.
Research for the development of a new fuel with low enrichment: Teresa Kiechle and Julian Becker in the uranium laboratory of the FRM II.
Image: T. Hase / TUM
  • Research news
  • Reading time: 3 MIN

New fuel with low enriched uranium-molybdenum alloyPioneering work: Prototype of a new fuel

The Technical University of Munich (TUM) and Framatome are working together on the development of a new fuel for the research neutron source Heinz Maier-Leibniz (FRM II). The fuel shall consist of low-enriched, monolithic uranium molybdenum alloy (U-Mo). The first prototypes are expected to be manufactured in early 2021. If the tests are successful, production could start as early as 2022.

The Technical University of Munich and the French fuel element manufacturer Framatome have agreed to collaborate with the aim of producing new, low-enriched fuel elements for the research neutron source Heinz Maier-Leibnitz in Garching north of Munich.

The contract provides for a joint pilot project to manufacture a monolithic U-Mo fuel with an enrichment of 19.75%. It includes the development of a pilot production line and thus the production of fuel plates for radiation tests. These tests are a central part of the qualification of the new fuel especially for research reactors in Europe.

"We have invested many years of research work," says TUM President Prof. Thomas F. Hofmann. "With this project we are on the way to the future. We want to create the basis for the use of safe, low-enriched research neutron sources in science as well as for medical and industrial applications."

First results expected for 2022

The pilot production will be set up at Framatome's new research and development laboratory, the "CERCA Research and Innovation Laboratory", in Romans-sur-Isère in France. Six specialists form the project team, including scientists from TUM.

A TUM PhD student will be working directly at Framatome on the pilot production line from summer 2020. The production line will go into operation as early as the beginning of 2021 and will supply fuel for irradiation tests and qualifying from 2022. In the initial phase, certain sub-steps will be supplied from the TUM laboratories.

Cooperation with Belgium and France

TUM and Framatome are carrying out these irradiation tests within the framework of European projects in which the French Alternative Energies and Atomic Energy Commission (CEA), the research institute Laue-Langevin and the Belgian nuclear research centre (SCK-CEN) are also involved.

"The development of this fuel is a big step forward, several international teams have been researching this task for years. The success of this project will be of great importance worldwide", says Prof. Dr. Peter Müller-Buschbaum, scientific director of the FRM II.

Other research reactors worldwide benefit

The monolithic U-Mo fuel opens up new possibilities for conversion to lower enrichment fuels, not only for FRM II, but for research reactors worldwide.

"We are offering research reactors an alternative way to maintain the high neutron flux for research, industry and medicine, while reducing the enrichment of the fuel", says Francois Gauché, Director of Framatome-CERCA.

As soon as this fuel with lower enriched uranium – ideally with an enrichment below 20 percent – is qualified and industrially available, research reactors such as FRM II can start to convert to the new fuel.

Corporate Communications Center

Technical University of Munich Anke Goerg (FRM II) / Andreas Battenberg
battenberg(at)zv.tum.de

Article at tum.de

First author Sebastian Gruber and Prof. Dr. Petra Foerst evaluating the data of the freeze drying experiments.

Preserved and fresh

Freeze drying has provided us with tasty dried fruits in muesli, long-life yoghurt cultures and many other important products. For the first time, using neutron beams from the Heinz-Maier-Leibnitz (FRM II) research neutron...

FRM I (links) und FRM II auf dem Campus Garching - Bild: Andreas Battenberg / TUM

Anniversary of most powerful neutron source worldwide

For exactly ten years the Heinz Maier-Leibnitz research neutron source (FRM II) of the Technische Universität München (TUM) has been providing research, industry and medicine with neutrons. Built to the latest safety...

Metallisches Terbium. (Foto: Astrid Eckert / TUM)

Radionuclide treatment against small tumors and metastases

Medicine could very soon have a new ally in the fight against cancer: Terbium-161. Its most important weapon: Conversion and Auger electrons. Researchers at the Technische Universität München (TUM) have developed a new...